To review the interactions between herbs and widely used drugs and summarize the associated experimental methods.
INTRODUCTION
Herbal medicines have been used for more than 5000 years. 1 However, in ancient times only single herbs were ingested. 2 Today, herbal medicines are frequently used, especially among women and patients with chronic diseases. 3 Approximately 15%-20% of individuals taking prescription medications use herbal supplements. However, fearing censure, they may not be forthcoming to their physicians about their personal use of herbal medicines, even if they experience severe side effects. [4] [5] [6] The interactions between herbs or dietary supplements and drugs requires attention, especially for the elderly, frail, or those taking multiple medications for chronic diseases. 7 Several important foods such as grapefruit juice, and herbals such as Yinxingye (Ginkgo biloba. L) have been reported to cause clinically significant adverse drug reactions. 8 Ginkgo products administered concurrently with aspirin, warfarin (Coumadin), or ticlopidine (Ticlid) interact and can cause bleeding. Additionally, St. John's wort (SJW) 9 and antidepressants administered together cause side effects such as gastrointestinal disturbances and allergic reactions. The safety of herbs is mostly dependent on empirical experience, but these observations are not always effective at limiting side effects. Sometimes, the first signs of adverse effects take a long time to be recognized or they are recognized even after the patient has stopped using the herbs. Additionally, the ingestion of herbs is easily overlooked, therefore more publicly available information should be provided. 10 Extensive research into herb-drug interactions should be conducted to provide more information for patients and health care providers. A search of PubMed into the study of herb-drug interactions revealed that the choice of methods can have a profound impact on the experimental results, primarily because of the complex mechanisms involved. Herein, we summarize the methods used to study the interactions of individual herbal ingredients, crude herb extracts, and herbal formulas with drugs, and their mechanisms of action, and classify the experiments according to the different models employed.
Mechanisms of herb-drug interactions
Drugs usually contain single chemical entities, while almost all herbal products contain mixtures of pharmacologically active constituents. As such, herb-drug interactions could occur more frequently than drug-drug interactions, 11 and the mechanism of herb-drug interactions may be more complex. In vitro and in vivo studies, clinical trials and case reports demonstrated that herbal agents, particularly SJW and Yinxingye (Ginkgo biloba. L), interact with several prescribed medications and affected their pharmacokinetic profiles. In most herb-drug interactions, the cytochrome P450 (CY-P450) system and the efflux drug transporter P-glycoprotein (P-gp) play an important role. 1 More than half of the herbs ingested likely interact with the CYP system, which is also responsible for metabolizing many medications that inhibit and induce drug metabolism, and the P-gp, which is also important in herb disposition.
Research suggests that the mechanisms regulating herb-drug interactions often involve CYP isoforms. For example, studies on SJW used various animal models to study the different mechanisms involving CYP3A4, CYP2C19, and P-gp. The results indicated that the interactions observed in vivo with different drugs was similar to those observed using animal models. [12] [13] [14] [15] [16] [17] The relative abundance of the CYP isoforms are 30% CYP3A4, 13% CYP1A2, 7% CYP2E1, 4% CYP2A6, 2% CYP2D6, 20% CYP2C, and 1% CYP2B6 in human hepatic smooth endoplasmic reticulum where 50% of drug metabolism occurs via CYP3A4, followed by 25% CYP2D6 and 20% CYP2C. 18 In these studies, CYP3A4 mainly mediated the drug interaction via the CYP system, especially for SJW. The mechanisms of herb-drug interactions also involve different transport proteins, especially P-gp. P-gp, an ATP (adenosine triphosphate)-dependent membrane transporter, 19 is expressed in a broad range of tissues including the colon and intestinal mucosa, blood-testis capillary epithelial cells, liver cells, the adrenal gland and kidney proximal tubules. It works to decrease the oral absorption, intracellular concentration and bioavailability of xenobiotics. 20, 21 In the ATP binding cassette (ABC) family, P-gp is the largest subgroup, which also includes multidrug resistance-associated protein P1 (MRP1) and ABCG2. 22 Most of the interactions between herbs and drugs is P-gp-mediated, while interactions with other drugs, such as baicalein, involves MRP1, MRP2 and ABCG2. 23 In vitro research studies were conducted to assess the activity of the enzymes involved by determining the cytoplasm or the microsome involvement, and these were sometimes followed by in vivo studies that assessed the herb-drug interactions. Not all studies investigate the herb-drug interactions at the metabolism level, but still provide useful information. For example, Aurantium caused enhancement of gastrointestinal motility at the peak plasma concentrations of amiodarone. 24 Additional studies may be required to determine the mechanisms involved.
Summary of the experimental methods used to study the interactions of single component herbs with drugs
Studying single herb components can provide specific information about the nature of the herb and its mechanism of interaction. Research on Chuanxinlian (Herba Andrographitis Paniculatae) extract and its major component, andrographolide, which interacts with theophylline, showed that certain components other than andrographolide inhibited theophylline elimination in rats, and that the mechanism involved andrographolide-induced induction of CYP1A2. 25 Thus, studies of the isolated herb component provided useful information on its mechanism of action. A total of 28 single herb components known to interact with drugs are listed in Table 1 . The information has come from clinical trials and animal and cell studies. Animal models and cell culture experiments are commonly used to study drug interactions. Animal models were used to investigate the interactions between baicalin and rosuvastatin, 26 resveratrol and pyrogallol, 27 Tanshinone Ⅱ A (T Ⅱ A) and warfarin, 28 ferulic acid and clopidogrel, 29 baicalin and midazolam, 30 rutaecarpine and theophylline, 31 sinomenine and paeoniflorin, 32 and curcumin and losartan. 33 Cell culture experiments were conducted to study the interactions between andrographolide, theophylline and dexamethasone, 34, 35 triptolide and cisplatin, 36 salvianolic acid B and rifampicin, 37 silibinin, trazodone and lasalocid, 38, 39 trichosanthin and imatinib. 40 and solamargine and epirubicin. 41 Research using animal models usually included analysis of the drug's pharmacokinetic parameters. For example, the end of the maximum plasma concentration (Cmax) of ferulic acid was significantly increased by 74.3% when clopidogrel was co-administered. Additionally, the peak time (Tmax) of ferulic acid was 3 and 3.76 times slower and the area under the concentration-time curve (AUC) was increased by 63.5% and 79.7% when co-administered with Honghua (Flos Carthami) or clopidogrel, respectively, compared with ferulic acid administration alone. 29 Studies on baicalin, 83 rutaecarpine, 31 sinomenine 32 and curcumin 100 were also conducted using this method. Other methods have been used to assess herb-drug interactions. For example, the measurement of glutathione-S-transferase (GST), glutathione reductase and glutathione peroxidase activity and the measurement of CYP1A1, CYP1A2 and CYP2E1 enzymatic activity were used to assess the interaction between resveratrol and pyrogallol. 27 Another example is the study of the active component of Danshen (Radix Salviae Miltiorrhizae), T Ⅱ A, which affects warfarin pharmacokinetics and accelerates warfarin metabolism. Warfarin and its metabolites were detected in high concentrations in urine and blood collected from rats that were orally dosed with warfarin together with T Ⅱ A, but when warfarin was orally administrated alone to rats, a low level of warfarin and only a few of its metabolites were detected in urine or blood. This could be because water-soluble sodium TⅡA sulfonate displaces warfarin from the warfarin-human serum albumin complex, resulting in an increase of free warfarin concentration in blood. 28 Cell culture experiments were used by some investigators in order to study pharmacokinetics as exemplified by the investigation into the interaction of trazodone and silibinin. 39 Alternatively, studies of the growth rate inhibition in K562 cells showed that trichosanthin has a synergistic effect with imatinib to induce K562 cell growth arrest, down-regulate p210 (Bcr-Abl) in a time-and dose-dependent manner, reduce its downstream signals, and stimulate the effect of tyrosine kinase inhibition by the human chronic myelogenous leukemia (CML) cell line, K562 (Ph + ). 40 Silybin was investigated using cell metabolism, cellular protein content, and Table 1 Crude extract and single-ingredient herbs that interact with drugs (continuted) Notes: AUC: area under the plasma concentration-time curve; CL: clearance; T1/2: elimination half-life; Vd, volume of distribution. Cmax: The maximum plasma concentration; MRT: mean retention time ; Tmax: time to peak; CYP: cytochrome P450; P-gp: P-glycoprotein; ATP : adenosine triphosphate; ABC : ATP binding cassette family; MRP1: multidrug resistance-associated protein P1; ABCG2: ATP binding cassette G2; MRP1/2: multidrug resistance-associated protein P1/2. cell membrane integrity. 38 Another study assessed HepG2 cell proliferation and CYP1A2 and CYP3A4 mRNA expression in the presence or absence of rifampicin, which interacted with salvianolic acid B. 37 The same study design was used for triptolide 36 and andrographolide. 35 Microsomal experiments have also been used to investigate herb-drug interactions, which involve using pooled human liver microsomes and rat liver microsomes. For example, a study conducted using pooled human liver microsomes indicated that the synergistic effect between beauvericin and ketoconazole on antifungal activity may occur through a pharmacodynamic function. 85 Studies on mollugin 91 and TⅡA 99 also used the microsomal method. Animal models have been combined with microsomal experiments or cell culture experiments to investigate drug interactions. Quercetin, 93 californine and protopine, 86 scutellarin 95 and silibinin 98 were studied using a combination of animal models and microsomal experiments. The pharmacokinetics of quercetin and scutellarin were investigated to assess their interaction with pioglitazone and phenacetin. Additionally, metabolite formation rates were detected. 86 Determination of the serum aminotransferase activity, bilirubin content and histological analysis indicated that silymarin prevented CYP2E1-and CYP1A2-mediated free radical generation, and thereby modulated the effect of individual and combined exposure to rifampicin and/or pyrogallol. Silymarin also restored GST, glutathione reductase and glutathione peroxidase levels in pyrogallol-and/or rifampicin-induced hepatotoxicity, which led to the scavenging of free radicals. 98 The pharmacokinetics of Schisandra lignans 97 and quercetin 93 were studied using a combination of animal models and cell culture experiments. The in situ intestinal perfusion model and the Caco-2 cell lysate model were used to study the interaction between Baicalein and acetaminophen, ( −)-epicatechin, piperine and curcumin. All the four selected compounds produced dose-dependently inhibited Baicalein glucuronidation and sulfation. 30 Scoparone was studied using primary hepatocytes, hepatoma cells and pooled human liver microsomes. The results of this study indicated that Scoparone induced CYP2B6 expression. 96 Research has also been conducted on the interactions between drugs and single herb components. Cell culture experiments have been performed on quercetin (an extract of gingko leaves) and isorhamnetin [a total flavone of Shaji (Fructus Hippophae)]. After coadministration with each other to rats, the Cmax, AUC0-72 h, and AUC0 -∞ of both isorhamnetin and quercetin significantly increased compared with single administration 90 Herbs are composed of many components. All studies reviewed thus far have investigated the interaction of a single herb component or the single herb, but there has been little information about the interactions between herbal ingredients. For example, studying gingko leaf extract and its interaction with drugs might encounter unknown challenges because of the potential interactions between two components of the herb, quercetin and isorhamnetin. Similar issues exist in other herb products where there may be interactions between multiple ingredients in one herb formula.
Summary of the experimental methods used to study the interactions of crude herbal extracts with drugs
A single herbal preparation may contain more than 100 components, all of which may have some biological activity. The herbs can potentially mimic, increase, or inhibit the effects of co-administered drugs through simultaneous effects on the same drug targets. 101 Thus, the interaction between a drug and the crude extract of one herb will likely be complex, and one herb may be the substrate for multiple enzymes. Researchers used different models to show the effects and mechanisms of herb-drug interactions. A crude extract of 38 herbs was shown to interact with drugs by using different models (Table 1) . These models include animal experiments, cell culture experiments, microsomal experiments and clinical trials. Animal experiments accounted for the largest proportion, while cell culture experiments and microsomal experiments were used less than clinical trials.
Examples of single methods and multiple methods used to assess the interactions of crude herbal extracts with drugs
Drug-herb interactions may be studied using only one method. Clinical trials were used to show the interaction of Renshen (Radix Ginseng) 67 and cranberry 46 with midazolam and warfarin, respectively. Animal models are commonly used to detect changes in pharmacokinetic parameters. For example, using both rat and rabbit models, co-administration of Hibiscus sabdariffal extract (HSE) with hydrochlorothiazide (HCT) increased and prolonged the AUC, Cmax, Tmax, the elimination half-life (T1/2) of HCT. 72 Xiaohuixiang (Fructus Foeniculi), 74 Fucus vesiculosus extract, 53 Gegen (Radix Puerariae Lobatae) 55 and S. frutescens 72 were also studied using animal models. Often, drug-herb interactions are studied using multiple methods, which most frequently involve animal models combined with in vitro studies. A combination of animal models and microsomal experiments were used for studies of Gancao (Radix Glycyrrhizae), Honghua (Flos Carthami), tenryocha, and rooibos tea. After an aqueous decoction of Glycyrrhiza uralensis was administered, the AUC of lidocaine was reduced by 41%, its clearance (CL) increased by 59% and its T1/2 decreased by 39% . The mechanism involved the ability of Gancao (Radix Glycyrrhizae) to activate the nuclear receptor, PXR, which is known to induce CYP3A. 54 Honghua (Flos Carthami) significantly inhibited CYP2D6 in vitro and in vivo, resulting in increases in the AUC0-inf, Cmax, and T1/2 of metoprolol because of a decrease in CYP2D6 catalyzed metabolism. 68 After combining tenryocha and rooibos tea, the AUC0-inf and the Cmax of midazolam (MDZ) (20 mg/kg) were reduced by more than 60% , suggesting that hepatic CYP3A and CYP2C11 might not be affected by the teas. 82 A combination of animal models and other in vitro studies was also used, including gut sac studies (ex vivo) and cell culture experiments to investigate the interactions of Ziran (Cuminum cyminum L.) and Huajuhong [Citrus grandis (L.) Osbeck] peel. The results from the ex vivo gut sac study suggested that the interactions might not be associated with intestinal P-gp. Additionally, co-administration of Huajuhong [Citrus grandis (L.) Osbeck] peel significantly increased the AUC0-t and Cmax of cyclosporine and the AUC0-t and Cmax of tacrolimus. 59 The compound 3',5-dihydroxyflavone 7-O-β-D-galacturonide-4'-O-β-D-glucopyranoside (CC-I), which is an aqueous extract of Ziran (Cuminum cyminum L.), enhanced the AUC of rifampin by 53% and its Cmax by 35% by increasing the rate of mucosal-to-serosal transfer of rifampin, but its Tmax remained unchanged. The altered bioavailability profile of rifampin was caused by the enhancing effect of this glycoside, and it is speculated that the mechanism may be related to P-gp and CYP3A4, because rifampin is a well-known inducer of P-gp and CYP3A4. 33 A combination of cell culture and microsomal experiments was used to study Tongguanteng (Radix seu Herba Marsdeniae Tenacissimae) extract. Pooled human liver microsomes and the human hepatoma cell line HepG2 was used, and the results showed that concomitant use of Tongguanteng (Radix seu Herba Marsdeniae Tenacissimae) extract with gefitinib significantly reduced CYP2D6 and CYP3A4 mRNA and protein expression in human hepatoma HepG2 cells. 73
Examples of the interactions of some common herbs with drugs and the associated methods used for investigations
Certain commercially valuable herbs have been studied by multiple researchers using different models. Examples include SJW [Guanyejinsitao (Hypericum perforatum L.)], Sutherlandia frutescens, Ginkgo biloba extract, Danshen (Radix Salviae Miltiorrhizae) extract, Echinacea purpurea extract and Dasuan (Bulbus Allii).
The interactions of SJW with various drugs have been extensively studied using clinical trials. SJW was shown to interact with docetaxel (through CYP3A4), 12 omeprazole (through CYP2C19), 16 norethindrone (through CYP3A), 102 and digoxin (through P-gp) 103 using clinical trials. Using a combination of animal models and an isolated perfused rat liver model, administration of the SJW extract resulted in a significant increase in tolbutamide AUC and T1/2 and a significant decrease in CL by altering CYP2C6 metabolism. There was also a significant decrease in the dextromethorphan AUC and T1/2 mediated by CYP2D2, and a significant increase in the dextrorphan AUC and the dex-tromethorphan CL. SJW extract administration also resulted in a significant decrease in the AUC and T1/2, and a significant increase in the CL of midazolam (through CYP3A2) and in the AUC of 4-hydroxymidazolam. 13 Additionally, using a combination of an animal model and an in situ single-pass intestinal 5-perfusion model showed that the SJW pretreatment group had a lower indinavir concentration in the liver than in the intestine with a perfusion flow rate of 1 mL/min. 14 A combination of the two methods was also used to examine the drug interactions for SJW extract. Human plasma was used to simultaneously assess its interactions with nifedipine and dehydronifedipine. 15 Clinical trials were used to assess interactions from GBE [Yinxingye (Ginkgo biloba L.)] extract with alprazolam. Simultaneous administration of GBE extract and alprazolam decreased the AUC, Cmax and Tmax. As alprazolam is a substrate of CYP3A4, these effects that were likely mediated by modulating CYP3A4. 75 A microsome model combined with an in vivo study indicated that the anticoagulation effects of warfarin were significantly attenuated by co-treatment with GBE, and the mechanism is CYP-mediated. 80 Animal models are commonly used alone to detect changes in drug pharmacokinetic parameters, and also interactions between herbs and drugs. For example, when GBE was administered to rats, the hypotensive effect of nicardipine, which is metabolized by CYP3A2 in rats, and the activity of liver glutathione S-transferase were significantly reduced. 75 Orally administered GBE or ethanol extract did not affect the pharmacokinetics after intravenous administration of nifedipine. The AUC and Cmax of nifedipine and the absolute bioavailability of nifedipine after oral administration were significantly increased by simultaneous oral treatment with GBE. GBE given orally to rats seems to inhibit CYP3A. 8 The GBE also interacted with theophylline, as observed by its altered pharmacokinetic parameters. 78 When Echinacea purpurea was co-administered with darunavir, the clinical pathology of Caucasian HIV-infected patients showed that there was little change in the darunavir pharmacokinetic parameters. This phenomenon was mediated by CYP3A4. 51 When Echinacea purpurea was administered to healthy volunteers, midazolam CL (hepatic and intestinal CYP3A) was significantly increased by 34%, the AUC was significantly reduced by 23% , and the oral availability was increased. In contrast, the CL of oral midazolam was not significantly altered. Echinacea dosing significantly reduced the clearance of oral caffeine (CYP1A2) by 26% , and the CL of oral tolbutamide (CYP2C9) by 11%, but this change was not considered to be clinically relevant because the 90% CIs were within the 80%-125% range. 50 Research on Dasuan (Bulbus Allii) interactions involved clinical trials. Dasuan (Bulbus Allii) was shown to interact with dextromethorphan, alprazolam and warfarin, and the interactions with dextromethorphan and warfarin were significant, but there were no significant differences with alprazolam. The interactions between dextromethorphan and alprazolam were mediated by CYP2D6 and CYP3A4, respectively. 104 Using a microsome model, a combination of Sutherlandia frutescens and midazolam was found to decrease the MDZ CL by 40% and the affect was mediated by CYP3A4/5. 70 An animal model was also used to investigate of the effects of Sutherlandia frutescens administration. After 5 days of chronic exposure to Sutherlandia frutescens, there was a 45% and 51% decrease in the AUC and Cmax values of nevirapine, respectively. The reduction in plasma concentration of nevirapine in a dose-dependent manner after long-term treatment is primarily because of enhanced metabolism catalyzed by elevated levels of CYP3A2. 71 Study of the Danshen (Radix Salviae Miltiorrhizae) extract revealed that Danshen (Radix Salviae Miltiorrhizae) did not change significantly as a result of P-gp-and CYP3A-mediated interactions because of the low in vivo exposure of its inhibitory components. 105 When human albumin was used as a model, treatment with 10, 25, or 50 μL Danshen (Radix Salviae Miltiorrhizae) extract increased the free salicylate by 27.5% , 39.3% and 58.8% , respectively. The ability of Danshen (Radix Salviae Miltiorrhizae) to displace salicylate from the protein-binding site was also investigated using a fluorescence polarization digoxin immunoassay. No significant change in free Danshen (Radix Salviae Miltiorrhizae) concentrations were noted when the free digoxin-like activity was measured at salicylate concentrations less than 100 mg/mL. However, when the salicylate concentrations were more than 150 mg/mL, the free Danshen (Radix Salviae Miltiorrhizae) concentrations was significantly decreased. 48 The examples provided for the six herbs were studied using different methods to identify the interactions mediated by single or multiple enzymes. The studies described above used crude herb extracts which may complicate the studies of the interaction when only one herb and one drug are involved. Studying the individual components that are related to the herb-drug interaction, and determining the mechanism of action for a specific component may provide more conclusive information. In summary, the interactions between the ingredients of the herbal formulae themselves should also be considered.
Interactions between herbal formulae and drugs
Herbal formulae usually include many herbs, and because interactions exist between the single herb components, we can hypothesize that there are likely interactions between the components of every herbal formula. The interactions between the ingredients of Huanglianjiedu Tang (HLJDT) have been studied. Compared with the control group, after oral administration of Radix scutellariae extract (188 mg/kg baicalin and 47 mg/ kg wogonoside) and HLJDT (193 mg/kg baicalin and 43 mg/kg wogonoside), the AUC of baicalin and wogonoside was decreased by 36% and 47% , respectively. The Cmax was also decreased by 4% for baicalin, but increased by 20% for wogonoside, and the T1/2 was increased by 14% for both. 106 The interactions of Shaoyaogancao Tang were studied to assess the pharmacokinetic parameters of albiflorin and paeoniflorin. When the active components of Radix paeoniae alba were administered with Shaoyaogancao Tang, the AUC0-inf of albiflorin and paeoniflorin was decreased by 36% and 48% , respectively, compared to co-administration of the single herb peony decoction, and the Cmax was decreased by 8.3% and 9.6%, respectively, but the T1/2 and Tmax showed no significant changes. 107 Animal models, which were used most frequently in the above studies, generally provide information about the pharmacokinetic parameters of drugs. PHY906, a Traditional Chinese Medicine formula that has been used for the last 1,800 years to treat distressing conditions of the gastrointestinal tract, was studied using an animal model. Murine Colon 38 cells were transplanted subcutaneously into four-to six-week-old female BDF1 mice, and after the treatments were administered, tumor tissue was removed, divided and frozen until the total RNA was isolated or histological analysis was performed. The results indicated that PHY906 and CPT-11 alone induced significant alterations in all evaluated tissues. However, the distinct alterations in the tumor, liver and spleen were reversed when the compounds were administered simultaneously with prevalent induction of pro-apoptotic and proinflammatory pathways that may favor tumor rejection. Currently, the mechanism and parameter values are not known. 108
CONCLUSIONS

Implications of herb-drug interactions
Clinical implications of herb-drug interactions depends on a variety of factors that are related to co-administered medicine (species, dose, dosing regimen, administration route, pharmacokinetic and therapeutic range) and have been previously reported. 109 Before designing an experiment, many factors should be taken into consideration. Herein, we comprehensively reviewed the available information on herb-drug interactions, and summarized and classified the general study designs based on the object of the experiment. Generally, in vitro studies, microsomal experiments and cell culture experiments were used in most studies.
In vivo studies most often involved animal experiments, and clinical trials were used less frequently. Many studies included a combination of in vivo and in vitro studies, and it was common that in vivo studies were combined with microsomal experiments or cell culture experiments. Results obtained from using a combination of methods likely better reflect metabolism and transport mechanisms.
Some special phenomena should be highlighted. For example, simultaneous administration of high-dose and low-dose andrographolide and theophylline could result in conflicting results for the AUC. 25 Varying the dose could have a more significant influence on the pharmacokinetic parameters than a single dose. However, when a single-dose of Fucus vesiculosus extract (575 mg/kg, p.o.) and amiodarone (50 mg/kg, p.o.) were co-administered by oral gavage, the AUC0-t, AUC0-inf and Cmax of amiodarone was decreased by 30% , 27% , and 55.4% , respectively. After pretreatment for 14 days, there were only minor changes in amiodarone parameters. 53 Not all studies were useful for identifying the mechanism, and many articles speculated on the mechanism based on the results. CYP and P-gp are the most common enzymes that mediate herb-drug interactions, but other enzymes are also mentioned. For example, it was found that curcumin could significantly increase the absorption of baicalein via MRP1-, MRP2and breast cancer resistance protein (BCRP)-mediated transport. 30 Herb-drug interactions can also be mediated via other mechanisms. For example, Zhiqiao (Fructus Aurantii Submaturus) peel increased the rate of gastrointestinal motility, resulting in altered pharmacokinetic parameters of amiodarone. 82
Key points to consider when identifying herb-drug interactions
Selection of the method and the details of the experimentation are the key points for a successful experiment. A successful experiment does not completely mimic previous research, but should consider the nature of the drug itself and the purpose of the study, which should be based on an extensive literature review.
The nature of the drug should determine how best to assess its efficacy. For example, because the administration of GBE for one month may improve peripheral diseases and dementia, the time of GBE treatment should be considered in the experimental design as it may be useful to administer GBE for more than 4 weeks to obtain a clinically relevant period for study. 110, 111 Warfarin is known to produce an anticoagulant effect, which is needed for the carboxylation of several blood coagulation proteins, and therefore, a few days are necessary after administration of warfarin for an effect to be observed. 87 Thus, when studying warfarin in rats, the (S)-form and (R)-form of warfarin should be administered on days 3 to 5 before the first sampling because of the time lag after administration between the maximum plasma warfarin concentration and its anticoagulant action. 112 The nature of each herb is different and certain experimental methods are necessary when studying the pharmacological properties of the drug. Additionally, the results should be obtained according to the study aims. For example, the interaction of GBE and theophylline was studied by administering theophylline orally and intravenously in order to distinguish between hepatic and intestinal metabolism. The results showed there was an equivalent reduction in the AUC of theophylline, indicating that oral pretreatment with GBE induced the hepatic metabolism of theophylline but not its intestinal metabolism. 79 A successful experiment should choose a method that can serve its required purposes. When studying drugherb interactions, the method used may be the most important factor to consider because choosing different models might affect the results. For example, in clinical treatment, the effect of GBE on the hepatic CYP activity (CYP1A2, CYP2D6, CYP2E1, and CYP3A4) in patients is different from that obtained from treatment of 12 healthy volunteers. 113, 114 The models described in this review include microsomal models, cell culture, animal models and clinical trials. Animal models were used by most groups, and clinical trials were used by only a few groups. Most microsome studies were combined with in vitro or in vivo studies to better evaluate the herb-drug interactions. The microsomal studies typically included human liver microsomes, rat liver microsomes, or other tissues and organs (intestine and kidney). When combined with in vivo studies, microsome experiments were usually used to assess the activity of the herbs on the enzymes by measuring the rate of drug metabolism, and to relate any changes observed to a concentration-inhibition curve. Similar to the microsomal experiments, cell culture was used to assess mRNA and protein expression after herb-drug treatment. Many kinds of cells were used in these studies including hepatocytes, Caco-2 cells, HepG2 cells, human normal urothelial cells, six urothelial cancer cell lines (RT112, RT4, KK47, TCCsup, EJ and J82) and a PC3 prostate cancer cell line, primary hepatocytes, hepatoma cells, and K562 cells. Cell culture experiments were also combined with in vivo studies. For example, Caco-2 cells and MDCKII/MDR1-MDCKII cell culture was combined with an in vivo study to validate whether isorhamnetin interacted with P-gp, and a pharmacokinetics study was conducted in rats. 89 In another study, an in vitro screen using Caco-2 cell monolayers were performed to investigate the influence of various components (quercetin, hesperetin, piperine, curcumin and naringenin) on the transport of irinotecan, and it was followed by an in vivo study. 92 In summary, both patients and healthy people should pay attention to the possible complications of herbdrug interactions because of the complex ingredients, and the universal applications of herbal products. Their interaction mechanisms are complex, and possible side effects are becoming more commonplace. The method chosen should play a decisive role in designing the studies to assess these herb-drug interactions.
